Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
3.510
-0.170 (-4.62%)
At close: Oct 22, 2024, 4:00 PM
3.520
+0.010 (0.28%)
After-hours: Oct 22, 2024, 7:59 PM EDT
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $208.57 million as of October 23, 2024. Its market cap has increased by 158.78% in one year.
Market Cap
208.57M
Enterprise Value
73.72M
1-Year Change
158.78%
Ranking
Category
Stock Price
$3.51
Market Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $208.57M, a decrease of -60.18%. That is a compound annual growth rate of -25.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2024 | 206.90M | 159.27% |
| Dec 29, 2023 | 79.80M | 69.79% |
| Dec 30, 2022 | 47.00M | -86.92% |
| Dec 31, 2021 | 359.40M | -31.38% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Procaps Group | 214.37M |
| Fulcrum Therapeutics | 211.54M |
| Corbus Pharmaceuticals Holdings | 210.29M |
| Cabaletta Bio | 209.56M |
| Bright Minds Biosciences | 208.09M |
| Adaptimmune Therapeutics | 207.15M |
| Organigram Holdings | 202.63M |
| Gossamer Bio | 201.23M |